Submitted by Anonymous (not verified) on 11 April 2024 - 13:48
Human medicines European public assessment report (EPAR): Febuxostat Viatris (previously Febuxostat Mylan), febuxostat, Date of authorisation: 15/06/2017, Revision: 13, Status: Authorised
Source: